Tadalafil Patent Expiration
Tadalafil is used for improving exercise ability in patients with Pulmonary Arterial Hypertension (PAH). It was first introduced by Eli Lilly And Co
Tadalafil Patents
Given below is the list of patents protecting Tadalafil, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Tadliq | US11382917 | Liquid oral formulations for tadalafil | Dec 24, 2038 | Cmp Dev Llc |
| Tadliq | US11666576 | Liquid oral formulations for tadalafil | Dec 24, 2038 | Cmp Dev Llc |
| Tadliq | US11975006 | Liquid oral formulations for tadalafil | Dec 24, 2038 | Cmp Dev Llc |
| Tadliq | US12186322 | Liquid oral formulations for tadalafil | Dec 24, 2038 | Cmp Dev Llc |
| Adcirca |
US6821975 (Pediatric) | Beta-carboline drug products |
May 19, 2021
(Expired) | Eli Lilly Co |
| Cialis |
US6821975 (Pediatric) | Beta-carboline drug products |
May 19, 2021
(Expired) | Lilly |
| Adcirca | US6821975 | Beta-carboline drug products |
Nov 19, 2020
(Expired) | Eli Lilly Co |
| Cialis | US6821975 | Beta-carboline drug products |
Nov 19, 2020
(Expired) | Lilly |
| Adcirca |
US7182958 (Pediatric) | β-carboline pharmaceutical compositions |
Oct 26, 2020
(Expired) | Eli Lilly Co |
| Cialis |
US6943166 (Pediatric) | Compositions comprising phosphodiesterase inhabitors for the treatment of sexual disfunction |
Oct 26, 2020
(Expired) | Lilly |
| Cialis |
US7182958 (Pediatric) | β-carboline pharmaceutical compositions |
Oct 26, 2020
(Expired) | Lilly |
| Adcirca | US7182958 | β-carboline pharmaceutical compositions |
Apr 26, 2020
(Expired) | Eli Lilly Co |
| Cialis | US6943166 | Compositions comprising phosphodiesterase inhabitors for the treatment of sexual disfunction |
Apr 26, 2020
(Expired) | Lilly |
| Cialis | US7182958 | β-carboline pharmaceutical compositions |
Apr 26, 2020
(Expired) | Lilly |
| Adcirca |
US5859006 (Pediatric) | Tetracyclic derivatives; process of preparation and use |
May 21, 2018
(Expired) | Eli Lilly Co |
| Cialis |
US5859006 (Pediatric) | Tetracyclic derivatives; process of preparation and use |
May 21, 2018
(Expired) | Lilly |
| Adcirca | US5859006 | Tetracyclic derivatives; process of preparation and use |
Nov 21, 2017
(Expired) | Eli Lilly Co |
| Cialis | US5859006 | Tetracyclic derivatives; process of preparation and use |
Nov 21, 2017
(Expired) | Lilly |
| Cialis | US6140329 | Use of cGMP-phosphodiesterase inhibitors in methods and compositions to treat impotence |
Jul 11, 2016
(Expired) | Lilly |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Tadalafil's patents.
Latest Legal Activities on Tadalafil's Patents
Given below is the list recent legal activities going on the following patents of Tadalafil.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Email Notification Critical | 06 Jun, 2023 | US11666576 |
| Mail Patent eGrant Notification | 06 Jun, 2023 | US11666576 |
| Patent Issue Date Used in PTA Calculation Critical | 06 Jun, 2023 | US11666576 |
| Recordation of Patent Grant Mailed Critical | 06 Jun, 2023 | US11666576 |
| Electronic Review Critical | 06 Jun, 2023 | US11666576 |
| Recordation of Patent eGrant | 06 Jun, 2023 | US11666576 |
| Patent eGrant Notification | 06 Jun, 2023 | US11666576 |
| Email Notification Critical | 18 May, 2023 | US11666576 |
| Electronic Review Critical | 18 May, 2023 | US11666576 |
| Issue Notification Mailed Critical | 17 May, 2023 | US11666576 |
Tadalafil's Family Patents
Explore Our Curated Drug Screens
Tadalafil Generic API Manufacturers
Several generic applications have been filed for Tadalafil. The first generic version for Tadalafil was by Teva Pharmaceuticals Usa and was approved on May 22, 2018. And the latest generic version is by Shandong New Time Pharmaceutical Co Ltd and was approved on Dec 4, 2024.
Given below is the list of companies who have filed for Tadalafil generic, along with the locations of their manufacturing plants worldwide.
1. ACCORD HLTHCARE
Accord Healthcare Inc has filed for 4 different strengths of generic version for Tadalafil. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2.5MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
| 5MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
| 20MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
| 10MG | tablet | Prescription | ORAL | AB1 | Oct 23, 2019 |
2. AJANTA PHARMA LTD
Ajanta Pharma Ltd has filed for 4 different strengths of generic version for Tadalafil. Given below are the details of the strengths of this generic introduced by Ajanta Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
| 2.5MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
| 5MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
| 10MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
Manufacturing Plant Locations New
Ajanta Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Ajanta Pharma Ltd as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
3. ALEMBIC
Alembic Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Tadalafil. Given below are the details of the strengths of this generic introduced by Alembic.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2.5MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
| 5MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
| 10MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
| 20MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
Manufacturing Plant Locations New
Alembic's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Alembic as present at those locations.
| Country | City | Firm Name | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||||
4. AMNEAL PHARMS CO
Amneal Pharmaceuticals Co Gmbh has filed for 4 different strengths of generic version for Tadalafil. Given below are the details of the strengths of this generic introduced by Amneal Pharms Co.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2.5MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
| 5MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
| 10MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
| 20MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
5. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 4 different strengths of generic version for Tadalafil. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
| 2.5MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
| 5MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
| 10MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
Manufacturing Plant Locations New
Aurobindo Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Ltd as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
6. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 4 different strengths of generic version for Tadalafil. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG | tablet | Discontinued | ORAL | N/A | Dec 29, 2020 |
| 10MG | tablet | Discontinued | ORAL | N/A | Dec 29, 2020 |
| 2.5MG | tablet | Discontinued | ORAL | N/A | Dec 29, 2020 |
| 5MG | tablet | Discontinued | ORAL | N/A | Dec 29, 2020 |
7. CIPLA
Cipla Ltd has filed for 4 different strengths of generic version for Tadalafil. Given below are the details of the strengths of this generic introduced by Cipla.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
| 2.5MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
| 5MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
| 10MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
Manufacturing Plant Locations New
Cipla's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Cipla as present at those locations.
| Country | City | Firm Name | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||||
8. DR REDDYS
Dr Reddys Laboratories Ltd has filed for 4 different strengths of generic version for Tadalafil. Given below are the details of the strengths of this generic introduced by Dr Reddys.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
| 2.5MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
| 5MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
| 10MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
9. FOURRTS LABS
Fourrts India Laboratories Private Ltd has filed for 4 different strengths of generic version for Tadalafil. Given below are the details of the strengths of this generic introduced by Fourrts Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2.5MG | tablet | Prescription | ORAL | AB1 | Aug 13, 2024 |
| 5MG | tablet | Prescription | ORAL | AB1 | Aug 13, 2024 |
| 10MG | tablet | Prescription | ORAL | AB1 | Aug 13, 2024 |
| 20MG | tablet | Prescription | ORAL | AB1 | Aug 13, 2024 |
10. HANGZHOU BINJIANG
Hangzhou Minsheng Binjiang Pharmaceutical Co Ltd has filed for 4 different strengths of generic version for Tadalafil. Given below are the details of the strengths of this generic introduced by Hangzhou Binjiang.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Prescription | ORAL | AB1 | Oct 27, 2020 |
| 2.5MG | tablet | Prescription | ORAL | AB1 | Oct 27, 2020 |
| 20MG | tablet | Prescription | ORAL | AB1 | Oct 27, 2020 |
| 10MG | tablet | Prescription | ORAL | AB1 | Oct 27, 2020 |
11. HETERO LABS LTD III
Hetero Labs Ltd Unit Iii has filed for 4 different strengths of generic version for Tadalafil. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd Iii.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
| 2.5MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
| 5MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
| 10MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
12. LUPIN LTD
Lupin Ltd has filed for 4 different strengths of generic version for Tadalafil. Given below are the details of the strengths of this generic introduced by Lupin Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
| 10MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
| 5MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
| 2.5MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
Manufacturing Plant Locations New
Lupin Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Lupin Ltd as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
13. MACLEODS PHARMS LTD
Macleods Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Tadalafil. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG | tablet | Prescription | ORAL | AB2 | Oct 16, 2019 |
| 10MG | tablet | Prescription | ORAL | AB1 | Oct 7, 2019 |
| 5MG | tablet | Prescription | ORAL | AB1 | Oct 7, 2019 |
| 2.5MG | tablet | Prescription | ORAL | AB1 | Oct 7, 2019 |
14. NORVIUM BIOSCIENCE
Norvium Bioscience Llc has filed for 2 different strengths of generic version for Tadalafil. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG | tablet | Discontinued | ORAL | N/A | Aug 3, 2018 |
| 5MG | tablet | Discontinued | ORAL | N/A | Apr 29, 2019 |
15. NOVITIUM PHARMA
Novitium Pharma Llc has filed for 3 different strengths of generic version for Tadalafil. Given below are the details of the strengths of this generic introduced by Novitium Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG | tablet | Prescription | ORAL | AB1 | Mar 3, 2023 |
| 5MG | tablet | Prescription | ORAL | AB1 | Mar 3, 2023 |
| 10MG | tablet | Prescription | ORAL | AB1 | Mar 3, 2023 |
Manufacturing Plant Locations New
Novitium Pharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Novitium Pharma as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
16. PRINSTON INC
Prinston Pharmaceutical Inc has filed for 4 different strengths of generic version for Tadalafil. Given below are the details of the strengths of this generic introduced by Prinston Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG | tablet | Prescription | ORAL | AB1 | Aug 11, 2022 |
| 5MG | tablet | Prescription | ORAL | AB1 | Aug 11, 2022 |
| 2.5MG | tablet | Prescription | ORAL | AB1 | Aug 11, 2022 |
| 10MG | tablet | Prescription | ORAL | AB1 | Aug 11, 2022 |
17. QILU PHARM HAINAN
Qilu Pharmaceutical Hainan Co Ltd has filed for 4 different strengths of generic version for Tadalafil. Given below are the details of the strengths of this generic introduced by Qilu Pharm Hainan.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2.5MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
| 5MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
| 10MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
| 20MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
18. RISING
Rising Pharma Holding Inc has filed for 3 different strengths of generic version for Tadalafil. Given below are the details of the strengths of this generic introduced by Rising.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG | tablet | Discontinued | ORAL | N/A | Apr 29, 2019 |
| 2.5MG | tablet | Discontinued | ORAL | N/A | Apr 29, 2019 |
| 10MG | tablet | Discontinued | ORAL | N/A | Apr 29, 2019 |
Manufacturing Plant Locations New
Rising's manufacturing plants are situated in 3 countries - United States, Mexico, India. Given below are the details of these plant locations as well as the firm names of Rising as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||||
| Mexico |
| |||||||||||||||||||
| India |
| |||||||||||||||||||
19. SHANDONG
Shandong New Time Pharmaceutical Co Ltd has filed for 4 different strengths of generic version for Tadalafil. Given below are the details of the strengths of this generic introduced by Shandong.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG | tablet | Prescription | ORAL | AB1 | Mar 4, 2024 |
| 2.5MG | tablet | Prescription | ORAL | AB1 | Dec 4, 2024 |
| 10MG | tablet | Prescription | ORAL | AB1 | Dec 4, 2024 |
| 5MG | tablet | Prescription | ORAL | AB1 | Dec 4, 2024 |
Manufacturing Plant Locations New
Shandong's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Shandong as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| China |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
20. SUN PHARM
Sun Pharmaceutical Industries Ltd has filed for 4 different strengths of generic version for Tadalafil. Given below are the details of the strengths of this generic introduced by Sun Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2.5MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
| 5MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
| 10MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
| 20MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
Manufacturing Plant Locations New
Sun Pharm's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Sun Pharm as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||||||||||||||
| India |
| |||||||||||||||||||||||||||||
21. SUNSHINE
Sunshine Lake Pharma Co Ltd has filed for 4 different strengths of generic version for Tadalafil. Given below are the details of the strengths of this generic introduced by Sunshine.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG | tablet | Prescription | ORAL | AB2 | Nov 23, 2020 |
| 10MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
| 5MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
| 2.5MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
Manufacturing Plant Locations New
Sunshine's manufacturing plants are situated in 6 countries - United States, Peru, India, Thailand, China, Mozambique. Given below are the details of these plant locations as well as the firm names of Sunshine as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||||||||||||||||||||||||||
| Peru |
| |||||||||||||||||||||||||||||||||||||||||
| India |
| |||||||||||||||||||||||||||||||||||||||||
| Thailand |
| |||||||||||||||||||||||||||||||||||||||||
| China |
| |||||||||||||||||||||||||||||||||||||||||
| Mozambique |
| |||||||||||||||||||||||||||||||||||||||||
22. TEVA PHARMS INC
Teva Pharmaceuticals Inc has filed for 1 generic for Tadalafil. This 20mg version comes by the name ALYQ. Given below are the details of the strengths of this generic introduced by Teva Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG | tablet | Prescription | ORAL | AB2 | Oct 12, 2022 |
23. TEVA PHARMS USA
Teva Pharmaceuticals Usa Inc has filed for 4 different strengths of generic version for Tadalafil. Out of these 20mg version comes by the name ALYQ. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet | Prescription | ORAL | AB1 | May 22, 2018 |
| 2.5MG | tablet | Prescription | ORAL | AB1 | May 22, 2018 |
| 20MG | tablet | Prescription | ORAL | AB2 | Feb 5, 2019 |
| 5MG | tablet | Prescription | ORAL | AB1 | May 22, 2018 |
24. TORRENT
Torrent Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Tadalafil. Given below are the details of the strengths of this generic introduced by Torrent.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG | tablet | Prescription | ORAL | AB2 | Mar 26, 2019 |
| 10MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
| 5MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
| 2.5MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
Manufacturing Plant Locations New
Torrent's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Torrent as present at those locations.
| Country | City | Firm Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||
| United States |
| |||||||||||
25. UMEDICA
Umedica Laboratories Private Ltd has filed for 4 different strengths of generic version for Tadalafil. Given below are the details of the strengths of this generic introduced by Umedica.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2.5MG | tablet | Prescription | ORAL | BX | Oct 23, 2020 |
| 5MG | tablet | Prescription | ORAL | BX | Oct 23, 2020 |
| 10MG | tablet | Prescription | ORAL | BX | Oct 23, 2020 |
| 20MG | tablet | Prescription | ORAL | BX | Oct 23, 2020 |
Manufacturing Plant Locations New
Umedica's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Umedica as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
26. UNICHEM
Unichem Laboratories Ltd has filed for 4 different strengths of generic version for Tadalafil. Given below are the details of the strengths of this generic introduced by Unichem.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2.5MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
| 5MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
| 10MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
| 20MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
Manufacturing Plant Locations New
Unichem's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Unichem as present at those locations.
| Country | City | Firm Name | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||
| United States |
| |||||||||||||
27. VKT PHARMA
Vkt Pharma Private Ltd has filed for 4 different strengths of generic version for Tadalafil. Given below are the details of the strengths of this generic introduced by Vkt Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG | tablet | Prescription | ORAL | AB1 | Nov 4, 2021 |
| 2.5MG | tablet | Prescription | ORAL | AB1 | Nov 4, 2021 |
| 5MG | tablet | Prescription | ORAL | AB1 | Nov 4, 2021 |
| 10MG | tablet | Prescription | ORAL | AB1 | Nov 4, 2021 |
Manufacturing Plant Locations New
Vkt Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Vkt Pharma as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
28. WATSON LABS INC
Watson Laboratories Inc has filed for 4 different strengths of generic version for Tadalafil. Given below are the details of the strengths of this generic introduced by Watson Labs Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet | Prescription | ORAL | AB1 | Mar 29, 2019 |
| 2.5MG | tablet | Prescription | ORAL | AB1 | Mar 29, 2019 |
| 5MG | tablet | Prescription | ORAL | AB1 | Mar 29, 2019 |
| 20MG | tablet | Prescription | ORAL | AB1 | Mar 29, 2019 |
29. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 4 different strengths of generic version for Tadalafil. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2.5MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
| 5MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
| 10MG | tablet | Prescription | ORAL | AB1 | Mar 26, 2019 |
| 20MG | tablet | Discontinued | ORAL | N/A | Jun 6, 2023 |